Evommune, Inc. (EVMN)

13.66 -0.36 (-2.57%) USD  |  NYSE  |  Aug 24, 16:00
13.66 0.00 (0.00%) After-Hours: 20:00
More

Evommune Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for EVMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Return on Net Operating Assets Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
December 31, 2025 --
September 30, 2025 --

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
MapLight Therapeutics, Inc. Upgrade
Mineralys Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade